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Although extremely rare, the group of primary malignant tumors of the aorta (PMTA) exhibits enormous histologic
heterogeneity. In most cases, diagnosis is established late in the course of the disease; the median survival time is only a
few months. We present the case of a 75-year-old patient with an intimal angiosarcoma of the infrarenal abdominal aorta
and discuss the clinical presentation, histopathologic diagnosis, and classification of primary aortic sarcomas. A critical
review of the diagnostic and therapeutic management in this case revealed that the atypical aortic thrombus should have
prompted a comprehensive preoperative diagnostic work-up, specifically with magnetic resonance tomography of the
aorta and bone scintigraphy. (J Vasc Surg 2004;40:548-53.)PMTAs are extremely rare, with only about 120 cases
published in the world literature to date. The term primary
malignant tumor of the aorta subsumes a broad range of
histologically different malignancies. The terminology used
for the differentiation of these tumors is sometimes incon-
sistent and thus confusing. The literature contains only 21
cases of intimal angiosarcomas of the aorta diagnosed on
the basis of a proper histologic evaluation using standard
staining procedures and additional immunohistochemical
or electron microscopic studies. The biological behavior of
these tumors is highly aggressive, with a median survival
time of only a few months. Peripheral thromboembolic
complications are the typical clinical presentation. Several
authors recommend resection of the tumor-bearing aortic
region,1,2 but there is no proof that this approach is of any
benefit to the patient. Chemotherapy and radiotherapy
have proven to be of less value for the patient=s survival, but
may play a role in certain circumstances like inoperable
situations or metastatic complications.3 We describe a case
of primary intimal angiosarcoma of the infrarenal aorta and
review the available literature on the classification of pri-
mary aortic sarcomas.
CASE REPORT
A 75-year-old Caucasian woman presented with an acute
critical ischemia of the right lower extremity. The patient reported
paresthesia and a feeling of weakness in the right foot. She had no
history of claudication, and her vascular risk factors were hyperten-
sion and diabetes mellitus. She reported a 4-month history of
fatigue and weight loss. A previous diagnostic evaluation—includ-
ing a computed tomography (CT) scan of the thorax and upper
abdomen 2 months before her initial hospital admission—revealed
no pathologic features. Physical examination at the time of admis-
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doi:10.1016/j.jvs.2004.06.035548sion revealed normal pulses in the left lower extremity and only
femoral pulses palpable in the right. Laboratory studies showed no
abnormalities; the serum calcium level on admission was 9,5 mg/
dL.
Preoperative angiogram showed an embolic occlusion of the
right popliteal artery, with an infrarenal localized aortic thrombus
as the source of embolism (Fig 1). An aspiration embolectomy
performed immediately succeeded in restoring perfusion of the
right lower extremity. After exclusion of a cardiac thrombus by
echocardiography, an aortic thrombectomy of the distal aorta with
a Dacron patch angioplasty was performed 7 days after initial
aspiration embolectomy. Because of the atypical appearance of the
thrombus, a histopathologic examination was performed, which
showed the thrombus to conform with a primary intimal angiosar-
coma of the aorta (Fig 2). A CT scan of the thorax and abdomen
for staging of the malignant tumor disclosed no suspicious lymph-
adenopathy or metastases in liver, lung, or kidneys. After discuss-
ing the diagnosis with the patient and her family, the tumor-
bearing infrarenal aorta was resected 2 weeks later. Intraoperatively
obtained frozen sections of the proximal resection margins re-
vealed malignant cells up to the ostium of the left renal artery,
which was resected with tumor-free resection margins during the
same procedure (Fig 3). Vascular reconstruction was done with a
16-mm Dacron aortic prosthesis and an aortorenal 6-mm Dacron
bypass on the left side (Fig 4). Temporary impairment of renal
function after the operation was treated successfully with infusion
of a suitable quantity of colloids and crystalloids and application of
diuretics; no further postoperative complications occurred. The
patient was discharged home on the 14th postoperative day. The
pathology report confirmed the diagnosis of an intimal angiosar-
coma of the infrarenal aorta with tumor-free resection margins.
Roughly 4 weeks later the patient was readmitted to our
hospital with pain in the right thigh and hip joint and increasing
deterioration of her general condition. A radiograph of the right
femoral region at admission showed multiple osteolyses in the
femur and femoral neck. An intramedullary hip screw was inserted
to avoid a pathologic fracture in the right femoral region. A bone
scintigraphy performed 1 week later revealed further osteolyses in
the left femoral region and mainly degenerative changes in the
lumbar spine. Over the following 2 weeks the patient deteriorated
rapidly with increasing disorientation and somnolence. A CT scan
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in particular no evidence of cerebral metastasis that could explain
the neurologic status. Blood samples showed an increasing hyper-
calcemia, which was interpreted as paraneoplastic and attributed to
osteolytic bone metastases. In light of the poor prognosis of this
malignant disorder and the patient=s bad general condition with
Fig 1. Aortogram demonstrating a thrombus in the infrarenal
aorta without severe atherosclerotic changes of the aortic wall.
Fig 2. Immunohistochemical staining of endothelial-specific an-
tigen FLI-1 demonstrating a strong and specific positivity in the
cores of the tumor cells (arrows). By contrast, admixed non-
neoplastic peripheral blood cells of the adjacent thrombus show no
staining (arrowhead).clinical signs of hemolyses and multiorgan failure, therapy was
limited to an adequate analgesia. The patient died exactly 12 weeks
after initial hospital admission.
Postmortem examination disclosed no tumor residues at the
site of the reconstructed infrarenal aorta. There were no suspicious
regional lymph nodes and the complete remaining arterial vessel
tree was inconspicuous apart from moderate atherosclerotic
changes. Multiple osteolytic metastases were found in the femoral
regions on both sides and in the lumbar spine. There was no
evidence of further metastases in liver, lungs, kidneys, adrenal
Fig 3. Macroscopic view of the resected, tumor-bearing infrare-
nal aorta with small, greyish sarcoma residues growing incoher-
ently and mimicking atherosclerotic changes of the vessel wall
(arrow). At the upper margin of the specimen the patch angio-
plasty with suture material is visible (arrowhead).
Fig 4. Schematic illustration of the primary malignant tumor of
the aorta with tumor cells infiltrating the ostium of the left renal
artery (left). Replacement of the tumor-bearing aorta with a
16-mm Dacron aortic prosthesis and a left aortorenal 6-mm Da-
cron bypass (right).
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as cardiac failure in the context of the hypercalcemic crisis.
DISCUSSION
The terminology used to differentiate the extremely
rare PMTA is sometimes inconsistent and confusing. Prior
to the advent of immunohistochemistry, histopathologic
diagnosis of primary aortic malignancies relied solely on
light or electron microscopic identification of morphologic
features. This, however, is not adequate for the proper
differentiation of morphologically often very similar tu-
mors. Classification of PMTA requires the application of a
wide panel of immunohistochemical markers to reveal the
origin of the neoplastic transformation. The clinicopatho-
logic classification of Wright et al4 categorizes PMTA as
intimal (obstructive or nonobstructive) or mural, originat-
ing from the media or adventitia of the aortic vessel wall.
Electron microscopic studies have shown that the aortic
intima contains not only endothelial cells, but also smooth
muscle cells and fibroblasts, either of which is capable of
neoplastic transformation.5 On the basis of these electron
microscopical findings, aortic sarcomas, the most common
type of PMTA, should be further differentiated into intimal
angiosarcomas (of endothelial origin), intimal myofibro-
blastic sarcomas (of mesenchymal origin), and mural sarco-
mas of the aorta, depending on the immunohistochemical
pattern of the tumors (Fig 5).
The approximately 120 cases of PMTA published in the
literature represent a wide range of histologically distinct
entities. In a survey of the literature, Seelig et al1 discovered
87 cases of PMTA published from 1873 to 1998; a further
30 cases have been documented since then.6-30 Including
our own case, 21 cases of aortic intimal angiosarcoma based
on adequate immunohistologic evaluation have been de-
scribed in the literature (Table).
In our own case, the 4-cm aortic thrombus had the
typical microscopic appearance of an aortic intimal angio-
sarcoma, with a core of fibrin and necrotic tissue bordered
by a rim of viable, atypical epithelioid cells on the luminal
side. The immunohistochemical analysis showed positivity
Fig 5. Classification of aortic sarcomas.for endothelial markers (CD31, WT-1, FLI-1), the pan-
ceratin marker AE1/3, and vimentin, as well as negativity
for the mesenchymal markers desmin and actin. The pro-
liferation marker KI-67 stained about 50% of the malignant
cells; p53 was positive in about 20%.
The molecular background of intimal angiosarcomas of
the aorta is unknown, and to our knowledge they have yet
to be analyzed at the genetic level. In the study of Bode-
Lesniewska et al,31 8 intimal angiosarcomas arising in the
pulmonary artery, which is the most common localization
of these rare tumors, were characterized genetically by
using comparative genomic hybridization. The authors
found amplification and gains on the long arm of chromo-
some 12 with the minimal common region 12q13-14 in
75% of the examined tumors. Genes that are located in the
12q13-14 region are mdm-2, sas, cdk4 and hmgi-c. Immu-
nohistochemical studies showed that all 8 of these tumors
overexpressed mdm-2 on the protein level. The mdm-2
proto-oncogene is a negative regulator of p53 activity,
acting by binding to the p53 protein and accelerating its
degradation.32 In 7 of 8 tumors, p53 also was overex-
pressed immunohistochemically, which suggests that the
tumors may have had p53 mutations, although mutational
analysis of the p53 gene was not performed. These findings
implicate the mdm-2/p53 pathway as a possible mecha-
nism in the tumor pathogenesis. In the case presented here,
20% of tumor cells were positive for p53; in the only other
case subjected to immunohistochemical analysis of p53
reactivity, about 10% of tumor cells were positive.24 These
data suggest that changes in the p53 pathway might play an
important role in the pathogenesis of intimal angiosarco-
mas of the aorta.
Among the 21 reported cases of intimal angiosarcomas
of the aorta, 13 of the patients were male, 8 female. Their
mean age was 62.2 years (range, 46-75 years). The tumors
were located in the infrarenal aorta in 13 cases, in the upper
abdominal aorta in 3 cases, and in the thoracic aorta and
aortic arch in 5 cases.
The characteristic clinical feature at presentation of the
epithelioid intimal angiosarcomas of the aorta described in
the literature was—as in our case—the embolic occlusion of
a peripheral or mesenteric artery. Other clinical symptoms
were intermittent claudication, abdominal pain, back pain,
fatigue, and metastatic complications. The symptoms asso-
ciated with PMTA are nonspecific and elusive, mimicking
atherosclerotic disease of the aorta, peripheral arterial dis-
ease, renal colic, or herniated nucleus pulposes. In most
cases, the diagnosis of an intimal angiosarcoma of the aorta
is made antemortem by immunohistologic examination of
the endarterectomy or aortic resection specimen. In only 3
cases17,23,33 a malignant process in the aorta was suspected
preoperatively on the basis of magnetic resonance angiog-
raphy.
In patients presenting with peripheral or mesenteric
tumor emboli, a diagnostic algorithm proposes the exclu-
sion of a cardiac source of embolism with echocardiogra-
phy. Once a cardiac source has been excluded, magnetic
resonance angiography of the thorax and abdomen is con-
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an aortic tumor.34 The multiplanar structural imaging pro-
vided with this examination can distinguish an intraluminal
tumor mass from atheromatous material by enhancement
and can show the extent of tumor involvement of the aortic
wall and adjacent structures. Furthermore, it eliminates the
risk of embolization or contrast-induced renal failure asso-
ciated with conventional angiography.17
The biological behavior of epithelioid intimal angiosar-
comas of the aorta is very aggressive and thus the prognosis
Data on all patients diagnosed with primary intimal angios
Age (y)/sex Site of tumor Surgery Adj
1 67/male infrarenal aorta aortobiiliac bypass radio-
2 59/male infrarenal aorta aortobiiliac bypass chemo
3 58/male infrarenal aorta embolectomy chemo
4 52/female aortic arch graft interposition n.m.
5 67/male infrarenal aorta aortobiiliac bypass chemo
6 67/male thoracoabdominal
aorta
none none
7 71/female thoracic aorta endarterectomy none
8 69/male infrarenal aorta endarterectomy,
aortobiiliac bypass
radio-
9 73/female infrarenal aorta aortobiiliac bypass chemo
10 56/male suprarenal aorta endarterectomy none
11 69/female infrarenal aorta endarterectomy none
12 68/male infrarenal aorta endarterectomy none
13 48/female aortic arch none none
14 59/male infrarenal aorta aortobiiliac bypass none
15 64/female suprarenal aorta none none
16 75/female infrarenal aorta endarterectomy none
17 47/male infrarenal aorta endarterectomy,
aortobiiliac
bypass
chemo
18 63/male aortic arch graft interposition none
19 54/male infrarenal aorta aortobiiliac bypass radio-
20 46/male suprarenal aorta graft interposition none
21 75/female infrarenal aorta graft interposition none
n.m., Not mentioned.is very poor. Sixteen of the 21 reported cases (76,2%) had
metastases (the presence or absence of metastases was not
mentioned in one case33). The major locations of the
metastases were bone, liver, spleen, kidney, lung, and skin.
The mean survival rate of patients dying of the malignant
aortic tumor was 12.8 months (range, 1 week to 84
months). However, case reports of a patient surviving 8
years from diagnosis to death15 and of a patient with 4 years
of disease-free survival26 show that individual differences in
the clinical course of the disease are possible.
a of the aorta
t therapy
Metastases
follow-up Reference
motherapy skin death after 6
months
Becquemin
198835
py liver alive 11 months
after diagnosis
Weiss 19912
py liver, peritoneum death after 7
months
Burke 19933
n.m. n.m. Hashimoto
199333
py lung, liver, bone death after 6
months
Fehrenbacher
198136
spleen, bowel death after 2
weeks
(peritonitis due
to bowel
infarction)
Fitzmaurice
199037
tumor emboli in
liver, kidneys,
spleen and skin
death after 6
months
Seelig 19981
motherapy bone death after 7
years
Majeski
199815
py bone death after 10
months
Daniel 19979
bone, lung death after 13
months
Daniel 19979
bone alive after 12
months
Hottenrott
199912
none n.m. Hottenrott
199912
tumor emboli
in spleen,
brain
death after 1
week (cerebral
infarction)
Mohsen
200017
skin death after 8
months
Rudd 200023
tumor emboli
in intestine,
spleen and
kidney
death after 1
month
Santonja
200124
none alive Gittelman
200211
py none alive Shuster
200226
none alive Akiyama
20026
motherapy lung death after 17
months
Ghanem
200210
bone death after 18
months
Chiche
20037
bone death after 3
months
present casearcom
uvan
/che
thera
thera
thera
/che
thera
thera
/che
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comas of the aorta is difficult and challenging. Surgical
resection of the tumor-bearing aortic region with graft
interposition is the preferred therapy, although no data is
available showing a benefit to the patient. It is not known
whether endarterectomy without resection might not also
be an adequate therapy, since the malignant cells in intimal
angiosarcomas are limited to the luminal surface of the
thrombus. Adjuvant chemotherapy is to be applied in em-
bolic, metastatic, or nonresectable situations. According to
the European chemotherapy guidelines, the treatment of
aortic sarcomas is based on doxorubicin and ifosfamide.
External beam radiation could be used to treat bony me-
tastasis.
A critical review of the diagnostic and therapeutic proce-
dures applied in our own case revealed the following 3 major
points. First, a magnetic resonance tomography (MRT)of the
aorta should have been performed in response to the initial
unusual and suspicious aortogram showing a huge thrombus
without an aortic aneurysm or pronounced atherosclerotic
changes in the aortic wall (Fig 1). The MRT could have
provided preoperative confirmation of the presence of a pri-
mary malignant tumor of the aorta. Second, a bone scintigra-
phy should have been carried out as soon as a primary malig-
nant tumor of the aorta was suspected, since the rate of
osteolytic bone metastases is very high, with 7 of the 16
reported cases with metastasis involving bone. Once bone
metastases are confirmed, further major surgical intervention
may not be indicated since this situation is palliative with no
prospect of cure. Our patient was readmitted to hospital 4
weeks after initial aortic resection with multiple osteolytic
metastases in the femur on both sides and the lumbar spine.
The bone metastases could have been diagnosed prior to the
aortic resection if an early bone scintigraphy had been per-
formed; this probably would have changed our therapeutic
approach. Third, if the tumor-bearing aortic section is re-
sected, the resection margins should always be examined
intraoperatively on frozen sections, as in our case, since intimal
angiosarcomas of the aorta often have an incoherent growth
pattern.
In conclusion, intimal angiosarcomas of the aorta as a
subtype of PMTA are very rare, but should be suspected in
patients with an atypical aortic thrombus presenting with
symptoms similar to those of aortic occlusive disease or
acute thromboembolism. These symptoms usually present
late in the course of the disease, making surgery a palliative
procedure in most cases because of the presence of meta-
static disease. The critical review of the diagnostic and
therapeutic management of the present case reveals that the
detection of an atypical aortic thrombus should have
prompted a comprehensive preoperative diagnostic
work-up involving both MRT of the aorta and bone scin-
tigraphy.
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